Objective. To examine factors associated with Medicaid acceptance for substance abuse (SA) services by outpatient SA treatment programs. Data Sources. 
benefit elimination. Given the freeze on new enrollees accompanying SA and MH benefit reinstatement, no strong increase in treatment admissions was observed following the August 2004 policy change. A similar study examining opioid treatment found that during the time that Oregon removed the Medicaid SA treatment benefit, opioid users presenting to publicly funded treatment were less than half as likely to be placed in an opioid treatment program than before the benefit cut (Deck, Wiitala, and Laws 2006) .
Additional examples of Medicaid coverage impact on SA treatment access relate to pharmacological services. In a national treatment facility practice study, state policy limiting Medicaid SA treatment benefits reduced the likelihood of facilities offering naltrexone (used in treating alcohol dependence) (Heinrich and Hill 2008) . Similarly, a national study examining Medicaid coverage of buprenorphine (used in the treatment of opioid dependence) found that in states with coverage, programs were more likely to offer the treatment to clients (Ducharme and Abraham 2008) . While research indicates that Medicaid relates to SA treatment access, less evidence exists regarding treatment outcomes. A longitudinal study with over 200 Massachusetts adolescents seeking SA treatment showed no difference in treatment outcomes based on Medicaid managed care enrollment versus other publicly funded programs (Harrow et al. 2006) . Research with 517 patients admitted to New York hospital inpatient detoxification showed that patients with Medicaid coverage were at higher risk for discharge against medical advice (Blondell et al. 2006) . In California, 234 Medicaid recipients had lower odds of starting treatment and higher odds of treatment drop out than non-Medicaid patients (Walter et al. 2002) . Thus, the literature does not indicate that Medicaid enrollment guarantees improved SA treatment outcomes. However, it does indicate that Medicaid increases SA treatment access and can result in outcomes on par with those covered by non-Medicaid benefit programs.
A significant concern regarding U.S. health care access is limited provider willingness to accept Medicaid patients (Aday et al. 2004 ). In 2001, more physicians refused new patients with Medicaid coverage (21 percent) than the uninsured (16 percent). In comparison, only 5 percent of physicians refused privately insured new patients (Cunningham 2002) . By 2005, overall acceptance rates had not changed (Cunningham and May 2006) . Low reimbursement rates and increased administrative burden often are cited by physicians as reasons for not accepting Medicaid patients (Perloff, Kletke, and Fossett 1995; Jacobs, Wilk, and Rubio-Stipec 2005; Shen and Zuckerman 2005; Wilk et al. 2005) . However, other structural and environmental factors influence decisions regarding Medicaid acceptance. Cunningham and Nichols (2005) summarized several studies examining physician willingness to accept Medicaid and found the following factors were significant: type of physician practice, physician race/ethnicity and specialty, and community characteristics (income, patient insurance status). Descriptive research with national physician samples has shown that overall Medicaid patient acceptance is shifting away from (a) solo/small group practices to medium/large group practices and institutions, (b) general internists and family practitioners to pediatricians and specialists, and (c) large metropolitan areas to smaller metropolitan and rural areas (Cunningham and May 2006) . When comparing the effects of Medicaid fees versus the above factors, Cunningham and Nichols (2005) found that Medicaid fees had only indirect effects on patient access to care by influencing acceptance rates; in contrast, acceptance rates themselves had significant, direct effects on care access equity. Thus, practice structure and community characteristics may play key roles in access to care for Medicaid populations.
The literature discussed above has looked at the health care system in general. No available studies have examined factors related to SA treatment facility Medicaid acceptance. The current paper expands traditional research on health services access, cost, and quality issues (Aday et al. 2004) . N-SSATS is an annual survey of the location, characteristics, services, and number of clients enrolled in U.S. public and private SA treatment facilities as of March 31 of each year. N-SSATS' sampling universe includes all active treatment facilities in the Inventory of Substance Abuse Treatment Services and other facilities that are discovered during the first 3 weeks of the survey or added by state SA agencies. N-SSATS has a 95 percent response rate (USDHHS 2005) and has been shown to provide a satisfactory national sampling frame having accurately identified 70 percent of all SA facilities in a mid-size city (Carise et al. 2005) .
Data from 53,296 treatment program cases were obtained from N-SSATS data from the 50 states for the years [2003] [2004] [2005] [2006] . Publicly available N-SSATS datasets do not include unique treatment program identifiers; it is not possible to identify specific treatment programs across time. Thus, we refer to ''program cases'' as opposed to ''programs.'' Program cases not reporting standard or intensive outpatient treatment services were excluded (11, 889) . Also excluded were hospital-based program cases, those not accepting adults, and tribal or federally operated program cases, resulting in a final sample size of 31,129. Outpatient facilities were selected for analysis because, as the 2007 full N-SSATS data show, the vast majority of U.S. treatment programs offer standard outpatient (74 percent) or intensive outpatient (44 percent) services as compared with residential (27 percent), day treatment (15 percent), detoxification (21 percent), methadone maintenance (11 percent), or hospital inpatient (7 percent) services (USDHHS 2009 ). Thus, an interaction term was created to capture the likely importance of program cases reporting receiving public funding which were also located in states where Medicaid benefits covered outpatient SA treatment. The statutory and regulatory provisions were obtained through primary legal research conducted by staff at The MayaTech Corporation using searches of the relevant Westlaw state policy databases (detailed information on the policy data collection process can be found in Chriqui et al. 2007 Chriqui et al. , 2008 
Analytical Methods
After removing program cases with missing data on program-, county-, or state-level variables (other than special population programs), a total of 27,381 treatment program cases remained for analysis. These program cases were located in 2,110 counties and all 50 states, with an average of 548 program cases per state (range 86-3,379). As noted previously, publicly available N-SSATS datasets do not include a unique program identifier, and thus it is not possible to track individual facilities across time. Pooled cross-sectional analyses are thus complicated by the inability to control for the likelihood of having multiple observations for the same facility across time. The number of program cases per year ranged from 6,502 to 7,339, thus allowing overall analyses to be completed within a single year of data and then repeated by year to test for stability of results over time.
Analyses were conducted using svy commands in Stata v.10.1, specifying state as strata and county as the primary sampling unit to account for the lack of independence between program cases within the same county and state. The svy: mean command was used to obtain descriptive statistics, and the svy: logistic command was used for all multivariate models. Four multi-variate models (one for each of the 4 years) focused on predicting the odds of treatment program case acceptance of Medicaid for SA treatment while simultaneously controlling for all program-, county-, and state-level predictors other than special population programs. Additional models investigating the relationship between special population programming and Medicaid acceptance were run for each special population program separately by year (also simultaneously controlling for all other program-, county-, and state-level predictors; nine special population programs each run separately for the 4 years 5 32 models). In order to control for unmeasured state-level factors, state fixed effects were also included in all models. Table 1 provides descriptive information on all variables for all years combined. Just over half (55 percent) of all program cases reported accepting Medicaid for SA treatment services. Seventy-eight percent of program cases were located in states where Medicaid policy specifically allowed for SA treatment benefits. The average share of state Medicaid coverage devoted to nonelderly adults was 41 percent based on included program cases, while the average share of state general fund spending on Medicaid was 17 percent (averages based on total program cases in the analytical sample). Regarding program-level relationships that remain stable across years analyzed, all accreditation types were associated with increased odds of Medicaid acceptance, as was state SA agency licensure/certification. Compared with for-profit ownership, Medicaid payment acceptance was higher for both Notes.
RESULTS
Reported OR from models simultaneously controlling for all covariates noted above as well as state fixed effects using individual state dummies. Medicaid acceptance also was significantly and positively associated with the percentage of the state population reporting white race and the percent of the state population below the federal poverty level. The remainder of county-and state-level predictors showed no or inconsistent relationships with Medicaid acceptance.
The interaction of state Medicaid policy and program case acceptance of public funds was strongly and consistently related to Medicaid acceptance. Program cases accepting federal, state, county, or local government funding that were located in states with Medicaid coverage of SA treatment had higher odds of accepting Medicaid for such services. To further examine this interaction, a pattern variable was created identifying program cases as (1) neither publicly funded nor in a Medicaid SA treatment coverage state (7 percent of all program cases; 28 percent of which reported accepting Medicaid for SA treatment); (2) publicly funded, but not in a Medicaid SA treatment state (15 percent of all program cases; 61 percent of which reported accepting Medicaid), (3) not publicly funded but in a Medicaid SA treatment state (29 percent of program cases; 35 percent of which accepted Medicaid), or (4) both publicly funded and in a Medicaid SA treatment state (49 percent of program cases; 69 percent of which accepted Medicaid). One multivariate logistic regression model was run to examine the odds of Medicaid acceptance based on the pattern variable categories (due to the small percentage of program cases that neither accepted public funds nor were located in a Medicaid SA treatment coverage state, all years were combined in this model and year dummies were included to control for time). Results showed that program cases that both accepted public funds and also were located in a Medicaid SA treatment state had significantly higher odds of Medicaid acceptance than all other categories. Table 3 presents odds ratios from multivariate models predicting Medicaid acceptance where special population programming was the main predictor of interest. Separate models were run for each type of special population (controlling for all other variables previously discussed). Results showed that the odds of Medicaid acceptance increased across all years with offering special programming for dual-diagnosis clients and pregnant/postpartum women. criminal justice clients 5,966-6,740; dually diagnosed 5,790-6,655; gays/lesbians 6,151-7,085; persons with HIV/AIDS 6,104-6,952; pregnant/postpartum women 5,607-6,411; seniors 5,794-6,584; other women 5,760-6,649; other men 5,664-6,501.
w Percent of program cases accepting Medicaid for substance abuse treatment with and without predictor.
OR, odds ratios.
and state-level factors all significantly related to Medicaid payment acceptance for SA treatment services. Medicaid plays a key role in health care access for individuals seeking SA treatment; increased understanding of the factors related to program-level Medicaid acceptance may prove important in understanding and planning for how demand for such services may be met in the future. A key finding was that just under half of all outpatient treatment program cases in the sample (12,234, or 45 percent) did not accept Medicaid for SA treatment. Seventy-five percent of such program cases were located in states where Medicaid policy did allow for outpatient SA treatment services and yet these program cases chose not to accept Medicaid. To the extent that Medicaid plays a significant role in equity of health care access (Aday et al. 2004) , it is somewhat telling that individuals seeking outpatient SA treatment under Medicaid would either be turned away at one out of two treatment programs, or the facility would admit them but would then have to attempt to access other funding to reimburse treatment costs (in publicly funded programs, ''other funding'' would likely mean additional grant or contract funding). Such actions likely result in reduced potential treatment capacity and may affect access equity. Of the 9,233 program cases that reported not accepting Medicaid but that were located in states with Medicaid policy coverage of outpatient SA treatment services, 45 percent reported receiving public funds. Such apparent refusal to access available Medicaid reimbursement would appear to be poor policy. If a large percentage of these providers are not eligible to bill Medicaid for some reason, it may be important to evaluate whether they should receive public funding for addiction treatment services.
Given the recent passage of the Patient Protection and Affordable Care Act of 2010 (111 HR 3590; PL 111-148) , the lack of Medicaid acceptance for SA treatment services among program cases located in states with policy allowing such coverage is of particular concern. Estimates have stated that by 2019, the Act will expand Medicaid coverage by up to 15.9 million new enrollees (Holahan and Headen 2010) . Thus, SA treatment services for many of those currently uninsured may be reimbursed through Medicaid in the future. Further, the 2010 National Drug Control Strategy specifically calls for increased SA screening and early intervention in all health care settings, as well as expanding high-quality addiction treatment into general health care settings and increased use of mandated treatment for SA-using criminal offenders (Office of National Drug Control Policy 2010). SA treatment programs that do not accept Medicaid where state policy permits may simply not survive, and the treatment field cannot afford the resulting potential reduction in capacity at a time when demand will likely increase strongly.
Also important was the percentage of program cases that reported accepting Medicaid for SA treatment services but were not located in states with policy that allowed such coverage. Seventy-eight percent of all program cases were located in states where Medicaid policy specifically allowed for SA treatment services. However, of the remaining 6,034 program cases that were not located in such states, 50 percent (3,033) reported accepting Medicaid for SA treatment. This can be partially explained by recognizing that while all program cases were required to provide outpatient or intensive outpatient SA treatment services, some offered additional residential services. However, this was the case for only 27 percent of the 3,033 program cases that reported accepting Medicaid for SA treatment services in nonpolicy supporting states. The remainder (2,211 or 8 percent of the total sample) that did not offer any such services were primarily SA treatment focused (80 percent), not-for-profit (72 percent), reported receiving public funds (82 percent), and were spread out across 19 states. Whether these program cases represent billing for a service such as MH treatment, reporting error or inappropriate Medicaid use is unknown.
Program-level factors were strongly associated with Medicaid acceptance. Accreditation and licensure/certification by state SA agency were consistently associated with increased odds of Medicaid acceptance. This suggests that programs accepting Medicaid for SA treatment services may have more of a quality orientation by virtue of the fact that they have taken the extra step of obtaining national accreditation or licensure/certification--an entirely voluntary step found to relate to higher odds of offering wrap-around and continuing care services, all associated with improved long-term SA treatment outcomes (Chriqui et al. 2007 ). The increased likelihood of Medicaid acceptance at programs with large client counts is in line with previously discussed studies (Cunningham and May 2006) , and increased Medicaid acceptance at government and not-for-profit program cases (versus for-profit) is in line with findings related to decreasing private funding of SA treatment (Levit et al. 2008 ) and other ongoing research . Decreased Medicaid acceptance at private, for-profit programs may also help explain research finding decreased initial SA treatment access and shorter stays in treatment for clients unable to pay (Friedmann et al. 2003; Nahra, Alexander, and Pollack 2009) . Importantly, program cases that reported a primary focus of mental or general health were significantly and consistently more likely to accept Medicaid for SA treatment services than program cases focused on SA treatment. It is probable that non-SA treatment focused programs are more likely to accept Medicaid due to Medicaid's emphasis on providing health care for low-income and needy individuals. However, even when looking only at states allowing Medicaid to be used for SA treatment, only 52 percent of programs with a primary focus of either SA or combined SA/MH reported accepting Medicaid for SA treatment services compared with 74 percent for MHfocused and 65 percent for general health-focused programs. Clearly, more could be done to increase Medicaid acceptance for SA treatment in programs where such services are the main focus.
While proximal program factors had stronger relationships with Medicaid acceptance for SA treatment services than did more distal county-and state-level population characteristics, some key findings emerged. Program cases in counties with lower median household income showed higher odds of Medicaid acceptance, indicating that Medicaid indeed may be key in improving the equity of needed SA treatment access for those with few financial resources. State-level factors consistently and significantly related to Medicaid acceptance focused on poverty and the interaction between Medicaid policy and program acceptance of public funds. While mean state-level poverty levels did not differ numerically between program cases with and without Medicaid acceptance, controlling for program ownership allowed the direct effect of state poverty levels to significantly relate to increased Medicaid acceptance. SA treatment programs may be more likely to rely on Medicaid in states where poverty is especially high once program ownership is accounted for. Results also indicated that where state policy allows Medicaid to cover outpatient SA treatment, publicly funded facilities are more likely to accept such payments. Thus, one method of expanding service provision might be to encourage all states to allow Medicaid outpatient SA treatment payments in policy language. However, state efforts to cut overall costs may negatively affect the likelihood of such policy efforts. In addition, because of current and anticipated state reduction of Medicaid cost reimbursements, SA treatment programs may be less willing to accept Medicaid clients. It may be important for future research to examine what factors relate to state decisions to allow SA treatment coverage at the state level for Medicaid policy if equity of access is to be increased or maintained.
Outpatient SA treatment program cases offering programming for groups traditionally supported through Medicaid (dual-diagnosis clients and pregnant/postpartum women) did show higher odds of accepting Medicaid for SA treatment. In contrast, Medicaid acceptance was less likely for SA treatment program cases offering special programming for criminal justice clients from 2004 to 2006. Most states (90 percent) withdraw Medicaid enrollment when an individual is incarcerated (Wakeman, McKinney, and Rich 2009 ). However, for nonincarcerated individuals with justice system contact such as drug court clients, Medicaid remains the primary resource for health care payment (Nolan 2002) .
These findings should be viewed within their limitations. N-SSATS data are cross-sectional and cannot investigate causality. Further, since N-SSATS publicly available data do not include unique facility identifiers, individual client data (such as that from the public use Treatment Episode Data Set) cannot be matched with N-SSATS data to investigate whether Medicaid acceptance for SA treatment services relates to improved treatment outcomes. Finally, the present analyses have not exhaustively investigated all possible factors that might relate to treatment program decisions related to Medicaid acceptance for SA treatment services. However, the use of state fixed effects will have controlled for unobserved state-level factors.
CONCLUSION
The burden on the Medicaid system of providing SA treatment is significant. A study of Medicaid expenditures in six states showed that individuals with an SA diagnosis had significantly higher expenditures for physical health problems, and medical costs increased with age (Clark, Samnaliev, and McGovern 2009) . However, providing SA treatment can relate to significantly reduced overall medical costs (McLellan et al. 2000; Fleming et al. 2002) , which could, in turn, reduce the burden on state Medicaid budgets. The current analyses indicate that program-, county-, and state-level factors all relate to the likelihood of outpatient SA treatment programs accepting Medicaid for SA treatment. With the expected increase in Medicaid coverage resulting from the passage of the Patient Protection and Affordability Care Act and 2010 National Drug Control Strategy's call for increased SA treatment services provision across health care settings, it is crucial for the treatment field to move toward expanding Medicaid acceptance for SA treatment services. Efforts to increase Medicaid acceptance among outpatient SA treatment facilities--and thus ultimately improve equity of access for clients most in need of SA services--may be strengthened by (a) addressing state policy allowing coverage for SA treatment services under Medicaid, (b) increasing accreditation and licensure/certification requirements, and (c) focusing on reducing the barriers smaller programs face to accepting Medicaid.
